Apr 20, 2026 08:04AM LENZ submits UK marketing application for presbyopia treatment

Mar 25, 2026 07:08AM LENZ Therapeutics Inc (LENZ) PT Lowered to $26 at Citi

Mar 25, 2026 06:58AM H.C. Wainwright Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)

Mar 24, 2026 04:19PM LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 116c

Mar 24, 2026 03:58PM LENZ Therapeutics Inc (LENZ) PT Lowered to $29 at BofA Securities

Mar 24, 2026 01:01PM LENZ Therapeutics Inc (LENZ) PT Lowered to $39 at Piper Sandler

Mar 10, 2026 09:29AM William Blair Reiterates Outperform Rating on LENZ Therapeutics Inc (LENZ): "continue to believe VIZZ holds blockbuster potential"

Feb 4, 2026 05:36AM LENZ Therapeutics Inc (LENZ) PT Lowered to $35 at BofA Securities

Jan 5, 2026 08:04AM LENZ Therapeutics partners with Lunatus for VIZZ distribution in Middle East

Dec 12, 2025 04:28PM LENZ Therapeutics reports retinal tear in VIZZ patient with prior eye conditions

Nov 5, 2025 08:09AM LENZ Therapeutics, Inc. (LENZ) Misses Q3 EPS by 59c

Oct 27, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)

Oct 10, 2025 08:09AM LENZ Therapeutics Inc (LENZ) PT Raised at Piper Sandler Amid 'Strong Launch Potential For VIZZ'

Oct 6, 2025 04:29AM LENZ Therapeutics, Inc. (LENZ) call put ratio 4.3 calls to 1 put with a focus on January calls

Sep 30, 2025 08:06AM LENZ Therapeutics begins commercial distribution of presbyopia eye drop

Aug 22, 2025 06:52AM LENZ Therapeutics Inc (LENZ) PT Raised to $56 at H.C. Wainwright

Aug 4, 2025 06:37AM LENZ Therapeutics Inc (LENZ) PT Raised to $56 at H.C. Wainwright

Aug 1, 2025 11:11AM LENZ Therapeutics Inc (LENZ) PT Raised to $56 at H.C. Wainwright

Jul 31, 2025 05:25PM Lenz Therapeutics stock rises after FDA approves presbyopia eye drops

Jul 30, 2025 08:35AM LENZ Therapeutics, Inc. (LENZ) Misses Q2 EPS by 53c

Jul 28, 2025 07:08AM LENZ Therapeutics Inc (LENZ) PT Raised to $48 at H.C. Wainwright

Jul 7, 2025 10:37AM William Blair Reiterates Outperform Rating on LENZ Therapeutics Inc (LENZ) 'We see a potential blockbuster opportunity for LNZ100'

Jul 7, 2025 08:02AM LENZ Therapeutics (LENZ) licenses LNZ100 eye drop to Théa for Canada market

Jun 10, 2025 05:05AM Citi Opens 90-Day Positive Catalyst Watch on LENZ Therapeutics Inc (LENZ)

May 9, 2025 09:04AM LENZ Therapeutics (LENZ) and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia

May 7, 2025 04:57PM LENZ Therapeutics, Inc. (LENZ) Misses Q1 EPS by 53c

Apr 14, 2025 06:42AM Piper Sandler Starts LENZ Therapeutics Inc (LENZ) at Overweight

Apr 4, 2025 04:56PM LENZ Therapeutics, Inc. (LENZ) Files $500M Mixed Shelf

Apr 4, 2025 04:52PM LENZ Therapeutics, Inc. (LENZ) Files for 13.07M Share Offering by Selling Stockholders

Mar 20, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)

Mar 20, 2025 04:59AM LENZ Therapeutics Inc (LENZ) PT Raised to $47 at Citi

Mar 19, 2025 04:51PM LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 46c

Mar 17, 2025 04:06PM TD Cowen Upgrades LENZ Therapeutics Inc (LENZ) to Buy

Feb 18, 2025 09:47AM Citi Reiterates Buy Rating on LENZ Therapeutics Inc (LENZ)

Sep 27, 2024 05:47AM Raymond James Starts LENZ Therapeutics Inc (LENZ) at Outperform

Sep 11, 2024 04:12PM LENZ Therapeutics, Inc. (LENZ) Files for 1.58M Share Offering by Selling Stockholders

Aug 15, 2024 08:44AM Piper Sandler Reiterates Overweight Rating on LENZ Therapeutics Inc (LENZ)

Aug 15, 2024 04:58AM LENZ Therapeutics Inc (LENZ) PT Lowered to $32 at Citi

Aug 14, 2024 04:17PM LENZ Therapeutics, Inc. (LENZ) Misses Q2 EPS by 40c

Aug 12, 2024 06:12AM H.C. Wainwright Starts LENZ Therapeutics Inc (LENZ) at Buy